Tecmed

TecMed, Inc. is an intellectual property company based in Wyoming, specializing in patented optical measurement technology for blood glucose monitoring. Founded nearly two decades ago by a team of scientists and engineers, TecMed focuses on developing continuous, real-time, and non-invasive blood glucose measurement solutions, particularly for intensive and critical care environments. Their core technology offers over 50% more accuracy than competitors, enhancing patient healthcare outcomes through reliable and cost-effective solutions. In addition to its innovative measurement technology, TecMed AG, a related entity in Burgdorf, Switzerland, is expanding its presence in diabetes care by acquiring Ypsomed’s diabetes care business. This acquisition includes the development of insulin infusion systems and patch pumps, aiming to create a global leader in insulin pump systems. The combined expertise and products will enhance TecMed's commitment to diabetes care innovation and patient empowerment.

• Employees 360